You have managed to lead your finance organization through multiple rounds of private funding. You have supported your executives as they navigate the harrowing path of bringing a drug candidate out of the lab and into clinical trials. Now you are looking at raising capital in the public markets to continue to support that growth. Are you ready? Is your team ready? Are your accounting systems ready?
In this webinar we help Controllers, VPs of Finance and other finance team members grapple with these questions. We will cover:
In May 2020, Steve was selected as a senior analyst in RSM’s cutting edge Industry Eminence Program, which positions its senior analysts to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves. These senior analysts advise clients on conditions influencing middle market leaders. Steve’s focus is on the life sciences industry.
Kyle has assisted Life Sciences organizations with their technology transformations for 8 years. He is a key member of RSM’s Life Sciences team nationally and the Southwest market. Projects he has led range from pre-revenue organizations to commercialized entities, and exits.
Date: Thursday, November 18, 2021
Time: 1pm ET / 10am PT
Duration: 1 Hour
Now Available On-Demand